Wednesday, November 12, 2025
No menu items!
Home Blog Page 38

AI Won’t Fix Your Pipes: Mike Rowe Says Trades Are Real Job Security

0

Key Takeaways:

  • AI Shake-Up: Mike Rowe says coders aren’t safe—AI is coming for them.
  • Trades Thrive: Demand for welders, plumbers, and electricians is skyrocketing.
  • Urgent Gap: Construction needs 439K new workers in 2025—or costs will explode.

Mike Rowe, CEO of the MikeRoweWorks Foundation and host of How America Works on FOX Business, has a blunt message for anyone banking on tech careers to stay safe: Think again.

“We’ve been telling kids for 15 years to code. ‘Learn to code,’ we said,” Rowe told attendees at the Pennsylvania Energy and Innovation Summit on Tuesday. “Yeah, well, AI is coming for the coders.”

Rowe wasn’t done. While tech jobs face disruption, trade-based careers remain rock-solid. “Technology, however, isn’t coming for the welders… the plumbers, the steamfitters or the pipefitters… the electricians,” he said.

That’s not just tough talk—it’s economics. America’s skilled labor market is shrinking as older workers retire and too few young people enter the trades. McKinsey projects demand will surge thanks to infrastructure upgrades, energy projects, and real estate redevelopment. Meanwhile, the Associated Builders and Contractors (ABC) estimates construction alone will need 439,000 new workers in 2025 and 499,000 in 2026.

Fail to fill those roles? Expect soaring labor costs and fewer viable projects, warns ABC economist Anirban Basu.

Rowe has long sounded the alarm: “Every year, for every five tradespeople who retire, two people replace them… You can’t find a single major corporation today who relies on skilled labor [that] isn’t struggling to hire.”

Bottom line? AI might out-code you, but it can’t unclog a drain. For young Americans, the trades aren’t just a safe bet—they’re a gold mine.

Costco Bets on Coca-Cola Comeback as Trump Teases Sweetener Shake-Up

Key Takeaways:

  • Big Switch: Costco food courts are dropping Pepsi for Coca-Cola after 10 years.
  • Trump Factor: Speculation grows after Trump claims Coke may return to cane sugar.
  • Global Rollout: By fall, all 908 Costco locations worldwide will feature Coca-Cola products.

Costco is making a major change in its iconic food courts: Coca-Cola products are replacing Pepsi, a switch that began in early July and will be complete by fall, according to The Coca-Cola Company.

“Costco insiders and Coca-Cola fans are buzzing about the transition,” Coca-Cola said in a statement to FOX Business, noting that warehouses in 14 countries will soon feature Coke alongside Costco’s famous $1.50 hot dog combo. The move reverses a decade-long relationship with Pepsi that started in 2013.

The timing is notable. President Donald Trump recently announced on Truth Social that Coca-Cola plans to swap high-fructose corn syrup for cane sugar. While Coca-Cola has not confirmed the claim, the speculation has thrust the beverage giant into the spotlight. A shift to real sugar could position Coke as a premium, health-conscious alternative—at a time when consumer demand for clean-label products is surging.

Costco CEO Ron Vachris had hinted at the change in January, saying the retailer would “convert our food court fountain business back over to Coca-Cola” this summer. For Costco, ancillary offerings like food courts are key to driving member visits, along with gas stations, optical services, and tire centers.

The warehouse club currently operates 908 locations worldwide and plans to hit 914 by year-end. With Coke back on the menu, Costco is betting on nostalgia—and customer loyalty—to keep its foot traffic strong.

MAHA: Health Dept. Reclassifies Deadly Fentanyl Copycats

Why it matters:
The recent reclassification of nitazenes as a Class I substance in Pennsylvania underscores the urgent need for effective drug policy and law enforcement in combating the opioid crisis. This move not only empowers law enforcement to impose stricter penalties on traffickers but also highlights the ongoing challenges posed by synthetic opioids in the marketplace.

Key Takeaways:
– Pennsylvania Secretary of Health Debra Bogen announced the temporary rescheduling of nitazenes to a Class I substance, allowing for tougher penalties on trafficking and distribution.
– Nitazenes, developed in the 1950s and lacking any medical use, are reportedly more potent than fentanyl and have been linked to 45 deaths in Pennsylvania this year.
– The U.S. Drug Enforcement Agency supports similar federal action, as President Trump recently signed the HALT Fentanyl Act, solidifying the classification of fentanyl-related substances as Schedule I drugs.

The Big Picture:
The opioid crisis, initially fueled by prescription painkillers, has evolved into a more dangerous landscape dominated by synthetic opioids like nitazenes. By reclassifying these substances, Pennsylvania is taking a proactive stance to protect its citizens and uphold public safety. This decision reflects a broader commitment to fiscal responsibility and effective governance, ensuring that law enforcement has the tools necessary to combat drug trafficking while also prioritizing treatment for those struggling with addiction.

Moreover, the ongoing opioid epidemic poses significant economic implications. The rising number of overdose deaths not only affects families and communities but also places a strain on healthcare systems and local economies. By addressing the issue head-on, Pennsylvania is setting a precedent for other states to follow, reinforcing the importance of individual liberty and personal responsibility in the fight against substance abuse.

What They’re Saying
“Scheduling nitazenes, which have no acceptable medical use, as Class I substances provides law enforcement with the authority to crack down on its possession and distribution in Pennsylvania,” said Secretary Bogen. “Meanwhile, our focus remains on developing strategies that help connect people with substance use disorder with treatment and other resources.”

Go Deeper:
Original source: The Center Square
Author: Not specified
Original article title: “Pennsylvania reclassifies nitazenes as Class I substance amid opioid crisis”

Trump Pushes for Epstein Testimony Release, Slams ‘Radical Left Lunatics’

Key Takeaways:

  • Full Disclosure: Trump directs DOJ to release Epstein grand jury transcripts, pending court approval.
  • Calls Out Critics: Says “radical left lunatics” will never be satisfied, even with total transparency.
  • Legal Battle: Trump sues Wall Street Journal over “false” report of alleged Epstein birthday letter.

President Donald Trump announced Saturday that his administration is seeking court approval to unseal Jeffrey Epstein’s grand jury testimony, while warning critics that even full disclosure won’t satisfy what he called “troublemakers and radical left lunatics.”

“I have asked the Justice Department to release all Grand Jury testimony with respect to Jeffrey Epstein, subject only to Court Approval,” Trump posted on Truth Social. “With that being said, and even if the Court gave its full and unwavering approval, nothing will be good enough for the troublemakers and radical left lunatics making the request. It will always be more, more, more. MAGA!”

The Justice Department filed two motions Friday in the Southern District of New York requesting approval to release the transcripts, with redactions to protect victim identities and sensitive details. The move follows Trump’s directive to Attorney General Pam Bondi to “produce any and all pertinent Grand Jury testimony, subject to Court approval.”

Pressure has grown among Trump supporters for transparency after a DOJ memo concluded Epstein died by suicide and no “client list” existed—a finding skeptics say raises more questions.

Adding fuel to the controversy, the Wall Street Journal published claims of a provocative birthday letter allegedly sent by Trump to Epstein. Trump strongly denied the allegation, filing a defamation suit against the paper.

“The defendants concocted this story to malign President Trump’s character and integrity,” his legal team stated.

Trump urged Republicans to stop dwelling on the case and blasted Democrats for ignoring accountability when they had the chance: “BECAUSE THEY HAD NOTHING!!!”

Joy Reid Explodes After Morgan Questions Firing Narrative

0

Highlights:

  • Morgan Calls It Out: Piers Morgan tells Joy Reid her firing wasn’t about race or gender, sparking a heated exchange.
  • Reid Melts Down: Former MSNBC host erupts after Morgan plays emotional video of her reaction to losing her job.
  • Debate Goes Viral: Clash reignites conversation over identity politics and accountability in mainstream media.

Former MSNBC host Joy Reid faced a heated exchange with Piers Morgan after he aired a video showing her emotional reaction to being fired from the network. The moment quickly escalated when Morgan challenged Reid’s claims about why she was let go.

Morgan confronted Reid directly, saying: “Let’s be honest. I don’t think you were fired after all those years because of your skin color or because you’re a black woman.”

The statement sparked an immediate meltdown from Reid, who has repeatedly suggested her termination was linked to race and gender bias in the media industry. Morgan, however, pressed back, arguing that her firing likely had more to do with ratings and performance than identity politics.

The fiery exchange highlights growing tension over what critics call the left’s overuse of race as an excuse for failure. Many conservatives have pointed out that MSNBC’s declining viewership and shifting lineup decisions have impacted hosts across the board, regardless of race or gender.

Reid’s emotional defense only fueled debate online, with supporters rallying behind her and critics calling the exchange proof of mainstream media’s obsession with identity politics.

The confrontation underscores a broader cultural clash: should job performance matter more than race in the world of media? For many Americans, Morgan’s blunt assessment resonated. As the clip continues to circulate, one thing is clear—this is a conversation that isn’t going away anytime soon.

Trump Challenges DOJ Report, Pushes for Epstein Transcripts

Highlights:

  • Trump Demands Transparency: President Trump orders the DOJ to seek court approval to unseal Epstein grand jury testimony.
  • Bondi Responds Quickly: Attorney General Pam Bondi says the motion to unseal transcripts will be filed Friday.
  • Pressure Mounts: Move follows backlash over DOJ report dismissing claims of foul play in Epstein’s 2019

President Donald Trump announced that his administration will seek court approval to release grand jury testimony in the Jeffrey Epstein case, following outrage from supporters over a recent Justice Department report dismissing conspiracy theories about Epstein’s death.

“Based on the ridiculous amount of publicity given to Jeffrey Epstein, I have asked Attorney General Pam Bondi to produce any and all pertinent Grand Jury testimony, subject to Court approval. This SCAM, perpetuated by the Democrats, should end, right now!” Trump wrote on Truth Social.

Shortly after Trump’s post, Bondi confirmed that the Justice Department will file a motion Friday to unseal the transcripts. “President Trump – we are ready to move the court tomorrow to unseal the grand jury transcripts,” she stated on X.

The announcement comes after the DOJ concluded there was no evidence to support claims of foul play surrounding Epstein’s 2019 death. The disgraced financier, arrested twice on sex-trafficking charges involving minors, died in jail in what officials ruled a suicide.

Trump’s push reflects his promise of transparency. Bondi previously hinted at “major revelations,” including names and flight logs tied to Epstein’s network. Many conservatives see the DOJ’s findings as another attempt to bury the truth.

As calls for accountability grow louder, Trump is positioning himself as the leader willing to pull back the curtain on one of America’s most infamous scandals. His message is clear: the American people deserve the truth—no more cover-ups.

Dershowitz: Judges, Not Trump Team, Blocking Epstein Information

0

Highlights:

  • Dershowitz Points to Courts: Says two Manhattan judges—not Trump or Bondi—are blocking Epstein records.
  • Trump Pushes for Transparency: President orders DOJ to seek court approval to unseal grand jury testimony.
  • Bondi Confirms Action: DOJ prepared to file motion to release transcripts amid growing public pressure.

Legal scholar Alan Dershowitz is pushing back against claims that the Trump administration or Attorney General Pam Bondi are responsible for withholding key details in the Jeffrey Epstein case. Instead, Dershowitz says the real obstruction is coming from the courts.

“Many of the things that are being suppressed are being suppressed by two judges in Manhattan,” Dershowitz stated, pointing the finger directly at the judiciary.

This statement comes as President Donald Trump and Bondi move to unseal grand jury testimony related to Epstein, the disgraced financier who was charged with sex-trafficking minors and died in federal custody in 2019. Trump announced earlier this week that he instructed Bondi to file a motion asking the court to release the records, saying the American people deserve full transparency.

“Based on the ridiculous amount of publicity given to Jeffrey Epstein, I have asked Attorney General Pam Bondi to produce any and all pertinent Grand Jury testimony, subject to Court approval,” Trump wrote on Truth Social.

Bondi confirmed the plan, saying, “President Trump – we are ready to move the court tomorrow to unseal the grand jury transcripts.”

Dershowitz’s remarks add a new layer to the debate, suggesting that unelected judges—not the administration—are the ones keeping the Epstein files sealed. For many conservatives demanding answers, the question now is clear: Why are Manhattan judges blocking the truth? The push for transparency continues, and Trump’s team says they are ready to fight to bring everything into the light.

Trump Delivers Major Win in War on Drugs with HALT Act

Highlights:

  • Fentanyl Analogues Permanently Banned: The HALT Fentanyl Act classifies all fentanyl-related substances as Schedule I drugs, carrying the harshest penalties under federal law.
  • Tougher Penalties for Traffickers: Trafficking 100 grams or more triggers a 10-year mandatory minimum sentence, closing loopholes exploited by cartels and dealers.
  • Streamlined Research Access: New provisions simplify Schedule I research regulations while reaffirming strong legal precedent to prevent abuse.

In a move that could save millions of American lives, President Donald Trump announced he will sign the Halt All Lethal Trafficking of Fentanyl Act—better known as the HALT Fentanyl Act. This legislation takes an aggressive stance against the drug crisis that has ravaged communities nationwide, permanently classifying fentanyl-related substances as Schedule I controlled substances under the Controlled Substances Act.

Schedule I drugs are defined as having a high potential for abuse and no accepted medical use, carrying the strictest regulatory and criminal penalties. The Act ensures that fentanyl analogues—synthetic variations responsible for countless overdose deaths—face the same quantity thresholds and mandatory sentencing guidelines as fentanyl itself. For example, possession or trafficking of 100 grams or more triggers a 10-year mandatory minimum prison sentence.

Beyond enforcement, the bill also streamlines the research process for Schedule I substances, reducing bureaucratic hurdles for legitimate scientific study. Provisions include single-site registrations for related research facilities, inspection waivers in certain cases, and limited manufacturing allowances for small-scale research without separate licensing.

The legislation reaffirms the court’s interpretation in United States v. McCray (2018), which classified butyryl fentanyl as an analogue, reinforcing Congress’s commitment to closing loopholes exploited by traffickers.

President Trump’s move underscores his “America First” commitment to dismantle the fentanyl pipeline—much of it originating from China and Mexico—and protect American families from one of the deadliest scourges of our time. This is law and order at work, delivering real action against a synthetic killer destroying lives across this nation.

Retail Giant Launches Multi-Year Plan with New Stores and Digital Upgrades

0
  • Target plans to open 20 new stores in 2025 as part of a strategy to add $15 billion in profitable growth by 2030.
  • The company aims to open 300 stores over the next decade while investing in supply chains, technology, and remodeling existing locations.
  • Despite expansion plans, Target projects a sales decline for 2025, revising its earnings forecast lower.

Target is doubling down on growth despite a challenging retail environment, announcing plans to open 20 new stores this year as part of a strategy to drive $15 billion in profitable sales growth by 2030.

The Minneapolis-based retailer said it will launch at least eight locations in California, Connecticut, Florida, New Jersey, New York, and Pennsylvania by August, with nine more stores slated to open later in the fall. Four stores have already opened in 2025. These openings support Target’s broader plan to open 300 new stores over the next decade while remodeling existing locations.

“These will be mostly full-size stores, helping the company generate billions of dollars in incremental growth,” CEO Brian Cornell said during a March 2024 earnings call. He also outlined additional investments in supply chain and technology, with at least 10 new distribution centers planned over the next ten years.

Target is also making moves to strengthen its digital marketplace, expand product offerings, and improve its omnichannel experience. The company recently launched its Enterprise Acceleration Office, a multi-year growth initiative led by COO Michael Fiddelke, aimed at increasing speed, adaptability, and innovation.

However, the retail giant faces headwinds. Target projects a low-single-digit decline in sales for fiscal 2025, revising its previous forecast of modest growth. Adjusted earnings per share are expected to range between $7 and $9, down from earlier projections of $8.80 to $9.80.

Despite softer sales expectations, Target is betting big on expansion to secure long-term dominance in a highly competitive retail market.